Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.
Imperial College Healthcare NHS Trust, London, UK.
Europace. 2021 Feb 5;23(2):305-312. doi: 10.1093/europace/euaa248.
Rate adaptation of the action potential ensures spatial heterogeneities in conduction across the myocardium are minimized at different heart rates providing a protective mechanism against ventricular fibrillation (VF) and sudden cardiac death (SCD), which can be quantified by the ventricular conduction stability (V-CoS) test previously described. We tested the hypothesis that patients with a history of aborted SCD due to an underlying channelopathy or cardiomyopathy have a reduced capacity to maintain uniform activation following exercise.
Sixty individuals, with (n = 28) and without (n = 32) previous aborted-SCD event underwent electro-cardiographic imaging recordings following exercise treadmill test. These included 25 Brugada syndrome, 13 hypertrophic cardiomyopathy, 12 idiopathic VF, and 10 healthy controls. Data were inputted into the V-CoS programme to calculate a V-CoS score that indicate the percentage of ventricle that showed no significant change in ventricular activation, with a lower score indicating the development of greater conduction heterogeneity. The SCD group, compared to those without, had a lower median (interquartile range) V-CoS score at peak exertion [92.8% (89.8-96.3%) vs. 97.3% (94.9-99.1%); P < 0.01] and 2 min into recovery [95.2% (91.1-97.2%) vs. 98.9% (96.9-99.5%); P < 0.01]. No significant difference was observable later into recovery at 5 or 10 min. Using the lowest median V-CoS scores obtained during the entire recovery period post-exertion, SCD survivors had a significantly lower score than those without for each of the different underlying aetiologies.
Data from this pilot study demonstrate the potential use of this technique in risk stratification for the inherited cardiac conditions.
动作电位的速率适应确保了在不同心率下,心肌内的传导空间异质性最小化,从而提供了一种防止室颤(VF)和心脏性猝死(SCD)的保护机制,这可以通过之前描述的心室传导稳定性(V-CoS)测试来量化。我们假设,由于潜在的通道病或心肌病而有 SCD 中止史的患者,在运动后维持均匀激活的能力降低。
60 名个体(有中止 SCD 病史的患者 n=28,无中止 SCD 病史的患者 n=32)接受了运动平板测试后的心电图成像记录。这些患者包括 25 例 Brugada 综合征、13 例肥厚型心肌病、12 例特发性 VF 和 10 例健康对照者。数据被输入到 V-CoS 程序中,以计算 V-CoS 分数,该分数表示心室中没有明显心室激活变化的百分比,分数越低表明传导异质性越大。与无 SCD 中止病史的患者相比,SCD 组在最大运动时的 V-CoS 评分中位数(四分位距)更低[92.8%(89.8-96.3%)vs. 97.3%(94.9-99.1%);P<0.01],恢复期 2 分钟时更低[95.2%(91.1-97.2%)vs. 98.9%(96.9-99.5%);P<0.01]。在恢复后 5 或 10 分钟时,没有观察到明显的差异。使用整个运动后恢复期获得的最低 V-CoS 评分中位数,SCD 幸存者的每个不同潜在病因的评分均显著低于无 SCD 中止病史的患者。
这项初步研究的数据表明,该技术在遗传性心脏病风险分层中的潜在应用。